Prime Medicine Financials

$2.93

$-0.15 (-4.72%)

As on 25-Sep-2026 13:34EDT

Market cap

$566 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	4.07	4.63	2.98	--	5.21	--
Cost of Revenue	47.72	7.32	6.13	4.65	12.01	4.86
Gross Profit	-41.77	-2.69	2.98	-4.65	-12.01	-4.86
Operating Expenses	154.75	205.66	205.45	204.79	116.54	84.47
Operating Profit (EBIT)	-196.52	-208.35	-202.47	-204.79	-116.54	-84.47
Other Income	--	--	--	--	-6.23	--
Profit before Tax	-187.89	-201.14	-195.88	-198.41	-122.77	-165.85
Provision for Tax	--	--	--	-0.28	-0.95	-0.49
Profit after Tax (Net Income)	-187.89	-201.14	-195.88	-198.13	-121.82	-165.37
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-142.01	-184.12

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	39.81	120.87	153.15	133.07	316.27	239.56
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	177.54	184.42	106.40	4.36	17.33	4.31
Current Liabilities	31.69	37.45	37.96	56.42	26.71	57.98
Total Liabilities	280.73	342.73	297.51	193.85	360.31	301.86

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	152.24	161.44	85.62	50.88	63.70	31.28
Current Assets	96.80	181.29	211.89	142.98	296.62	270.58
Total Assets	280.73	342.73	297.51	193.85	360.31	301.86
Total Debt*	112.48	116.43	40.79	13.63	28.75	10.41
Net Current Assets	65.11	143.85	173.93	86.55	269.90	212.60

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-162.56	-122.87	-165.41	-131.83	-34.08
Cash Flow from Investing Activities	--	-108.76	68.46	18.71	-47.10	-73.63
Cash from Financing Activities	--	151.51	195.88	0.66	181.49	269.28
Net Cash Inflow / Outflow	--	--	--	--	2.57	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.14	-1.35	-1.65	-2.03	-1.25	-1.73
Cash EPS ($)	--	-1.30	-1.60	-1.99	-1.23	-1.72
Adjusted Book Value ($)	--	0.81	1.29	1.37	3.25	2.50
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.09	-1.04	-1.70	-1.36	-0.36
Free Cash Flow per Share ($)	--	-1.12	-1.10	-1.79	-1.52	-0.40

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-93.29	-115.01	-80.59	-40.95	-109.89
ROE (%)	-233.88	-146.81	-136.88	-88.19	-43.83	-121.13
ROA (%)	-63.28	-62.83	-79.73	-71.51	-36.79	-92.74
EBIT Margin (%)	-4,613.11	-4,342.44	-6,566.61	--	-2,356.41	--
Net Margin (%)	-4,613.11	-4,342.44	-6,566.61	--	12,002.07	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-17.90	0.55	--	-1.00	--	-1.00
EBIT Growth (%)	5.71	-2.69	-2.40	-55.81	25.98	-17,695.39
Net Profit Growth (%)	5.71	-2.69	1.14	-62.64	26.33	-4,749.47
EPS Growth (%)	28.69	0.18	0.19	-0.62	0.27	-47.49
Book Value Growth (%)	-52.32	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-2.57	-1.77	-4.35	-14.83	--
Price / Book Value	0.28	4.27	2.26	6.48	5.71	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.10	-2.32	-1.04	-4.04	-12.78	--
Close Price ($)	3.69	3.47	2.92	8.86	18.58	--
High Price ($)	6.94	6.94	9.77	21.48	21.73	--
Low Price ($)	2.28	1.11	2.56	5.54	14.52	--
Market Cap ($ Cr)	565.90	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.96	0.27	0.10	0.09	0.04
Short term debt to equity ratio	0.23	0.07	0.02	0.07	0.04	0.03
Current Ratio	3.05	4.84	5.58	2.53	11.10	4.67
Quick Ratio	3.05	--	--	--	--	--
Interest Coverage	--	--	--	--	-10.12	-2.03

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.01	0.01	0.01	--	0.02	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	504.84	920.52	936.83	87.66	63.30
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.